Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Animal Genome Biotech Raises $9M in Seed Funds

Brown bear

A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Gene-Edited Treatments in Works for Safer Cancer Therapies

T-cells and cancer cells

A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies

Pharma, Synthetic Bio Companies to Find Antibody Therapies

DNA chip graphic

A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies

Small Biz Grant Funds Superbug Therapy Technology

Pseudomonas aeruginosa

A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work. . . . → Read More: Small Biz Grant Funds Superbug Therapy Technology

AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

Lung cancer illustration

A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease. . . . → Read More: AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

CEPI Funding Covid-19 Variant Vaccine

SARS-CoV-2 particle

A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine

Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Mature neuron

A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Biotechs Partner on Synthetic Plant-Based Drugs

Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs

Moderna to Build mRNA Vaccine Plant in Canada

Syringes

The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada